Welcome to CDC Stacks | Increasing Fluoroquinolone Resistance in Campylobacter jejuni, Pennsylvania, USA,1982–200111 - 13951 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Increasing Fluoroquinolone Resistance in Campylobacter jejuni, Pennsylvania, USA,1982–200111
  • Published Date:
    Dec 2002
  • Source:
    Emerg Infect Dis. 8(12):1501-1503.
Filetype[PDF - 736.72 KB]


Details:
No Related Documents.
You May Also Like:
  1. Fluoroquinolone Resistance in Campylobacter jejuni Isolates in Travelers Returning to Finland: Association of Ciprofloxacin Resistance to Travel Destination
    Personal Author:
    Hakanen, Antti; Jousimies-Somer, Hannele; Siitonen, Anja; Huovinen, Pentti; Kotilainen, Pirkko;
    Published:
    Feb 2003
    Source:
    Emerg Infect Dis. 9(2):267-270.
    Description:
    Ciprofloxacin resistance was analyzed in 354 Campylobacter jejuni isolates collected during two study periods (1995-1997 and 1998-2000) from travelers returning to Finland. The increase in resistance between the two periods was significant among all ...
    File Type:
    Filetype[PDF - 789.06 KB]
  2. Campylobacter jejuni in Penguins, Antarctica
    Personal Author:
    Griekspoor, Petra; Olsen, Björn; Waldenström, Jonas;
    Published:
    May 2009
    Source:
    Emerg Infect Dis. 15(5):847-849.
    File Type:
    Filetype[PDF - 178.41 KB]
  3. Fluoroquinolone Resistance in Campylobacter Absent from Isolates, Australia
    Personal Author:
    Unicomb, Leanne; Ferguson, John; Riley, Thomas V; Collignon, Peter;
    Published:
    Nov 2003
    Source:
    Emerg Infect Dis. 9(11):1482-1483.
    Description:
    Fluoroquinolone resistance was detected in 12 of 370 Australian human Campylobacter isolates; 10 of these were travel-associated, and for 2 isolates travel status was unknown. No resistance was found in isolates known to be locally acquired. In Austr...
    File Type:
    Filetype[PDF - 185.10 KB]
  4. Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium
    Personal Author:
    Murray, Gerald L.; Bradshaw, Catriona S.; Bissessor, Melanie; Danielewski, Jennifer; Garland, Suzanne M.; Jensen, Jørgen S.; Fairley, Christopher K.; Tabrizi, Sepehr N.;
    Published:
    May 2017
    Source:
    Emerg Infect Dis. 23(5):809-812.
    Description:
    Escalating resistance to azithromycin and moxifloxacin is being reported for Mycoplasma genitalium in the Asia-Pacific region. Analyzing 140 infections, we found pretreatment fluoroquinolone-resistance mutations in parC (13.6%) and gyrA (5%). ParC S8...
    File Type:
    Filetype[PDF - 9.10 MB]
  5. Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates.
    Personal Author:
    Engberg, J.; Aarestrup, F. M.; Taylor, D. E.; Gerner-Smidt, P.; Nachamkin, I.;
    Published:
    2001 Jan-Feb
    Source:
    Emerg Infect Dis. 7(1):24-34.
    Description:
    The incidence of human Campylobacter jejuni and C. coli infections has increased markedly in many parts of the world in the last decade as has the number of quinolone-resistant and, to a lesser extent, macrolide-resistant Campylobacter strains causin...
    File Type:
    Filetype[PDF - 105.78 KB]